Valuation of an N-glycosylation profile of recombinant blood coagulation factor VIIa molecule
- Authors: Ustinnikova O.B1, Rounova O.B1, Movsesyants A.A1, Shukurov R.R2, Smolov M.A2, Khamitov R.A2
-
Affiliations:
- Scientific Centre for Expert Evaluation of Medicinal Products
- International Biotechnology Center «GENERIUM» LLC
- Issue: Vol 18, No 4 (2020)
- Pages: 50-55
- Section: Articles
- URL: https://journals.eco-vector.com/1728-2918/article/view/113296
- DOI: https://doi.org/10.29296/24999490-2020-04-08
- ID: 113296
Cite item
Abstract
Full Text
About the authors
O. B Ustinnikova
Scientific Centre for Expert Evaluation of Medicinal Products
Email: ustinnikova@expmed.ru
O. B Rounova
Scientific Centre for Expert Evaluation of Medicinal Products
A. A Movsesyants
Scientific Centre for Expert Evaluation of Medicinal Products
R. R Shukurov
International Biotechnology Center «GENERIUM» LLC
M. A Smolov
International Biotechnology Center «GENERIUM» LLC
R. A Khamitov
International Biotechnology Center «GENERIUM» LLC
References
- Sutkeviciute I., Mistiniene E., Sereikaite J., Bumelis V. The influence of different glycosylation patterns on factor VII biological activity. Biochimie. 2009; 91: 1123-30.
- Jurlander B., Thim L., Klausen N., Persson E., Kjalke M., Rexen P, Jorgensen T., Ostergaard P, Erhardtsen E., Bjorn S. Recombinant activated factor VII (rFVIIa): characterization, manufacturing and clinical development. Semin. Thromb. Hemost. 2001; 27: 373-84.
- Руководство по биоподобным биологическим лекарственным препаратам, содержащим в качестве действующего вещества белки биотехнологического происхождения: вопросы качества EMEA/CHMP/BWP/49348/2005
- Гармонизированное трехстороннее руководство ICH. Спецификации: Методы испытаний и критерии приемлемости биотехнологических/биологических препаратов. Q6B. 1999
- Нормативные правовые акты в сфере обращения лекарственных средств в рамках Евразийского экономического союза. Т. 3. Правила проведения исследований биологических лекарственных средств Евразийского экономического союза. М., 2017; 352
- Ceroni A., Maass K., Geyer H., Geyer R., Dell A., Haslam S.M. GlycoWorkbench: a tool for the computer-assisted annotation of mass spectra of glycans. J. Proteome Res. 2008; 7: 1650-9
- Ranzinger R., Herget S., von der Lieth C.-W, Frank M. GlycomeDB - a unified database for carbohydrate structures. Nucleic Acids Res. 2011; 39: 373-6.
- Klausen N., Bayne S., Palm L. Analysis of the site-specific asparagine-linked glycosylation of recombinant human coagulation factor VIIa by glycosidase digestions, liquid chromatography and mass spectrometry Mol. Biotechnol. 1998; 9: 195-204.
- Bohm E., Seyfried B., Dockal M., Graninger M., Hasslacher M., Neurath M., Konetschny C., Matthiessen P, Mitterer A., Scheiflinger F. Differences in N-glycosylation of recombinant human coagulation factor VII derived from BHK, CHO, and HEK293 cells. BMC Biotechnol. 2015; 15: 87-101.
- Ghaderi D., Taylor R., Padler-Karavani V, Diaz S., Varki A. Implications of the presence of N-glycolylneuraminic acid in recombinant therapeutic glycoproteins. Nature Biotechnol. 2010; 28: 863-7.